 |
 |

Retinopathy Progression and Visual Outcomes After Phacoemulsification in Patients With Diabetes Mellitus
Robert A. Mittra, MD;
Jesus L. Borrillo, MD;
Sundeep Dev, MD;
William F. Mieler, MD;
Steven B. Koenig, MD
Arch Ophthalmol. 2000;118:912-917.
Objectives To determine the rate of progression of diabetic retinopathy after phacoemulsification surgery, and whether surgeon experience and/or surgical duration adversely affect visual outcome.
Methods A retrospective review of 150 eyes of 119 diabetic patients who underwent phacoemulsification surgery during a 5-year period was performed. Data collected included patient age, sex, type and duration of diabetes, diabetic control, associated systemic health factors, preoperative visual acuity and retinopathy grade, duration of surgery, intraoperative complications, and postoperative course. The effect of these factors on visual outcome and rate of retinopathy progression was studied by means of univariate and stepwise multivariate logistic regression analyses. Resident and private cases were compared.
Results Visual acuity improved by 2 or more lines in 117 eyes (78%); 93 eyes (62%) had a final visual acuity of at least 20/40. Retinopathy progression was seen in 37 eyes (25%) with 6 to 10 months of follow-up. Preoperative nonproliferative diabetic retinopathy, proliferative diabetic retinopathy, and limited surgical experience were statistically associated with retinopathy progression and poor visual outcome.
Conclusions The visual results and rate of retinopathy progression after phacoemulsification surgery in our series did not differ significantly from those reported that used other techniques. Nonproliferative and proliferative diabetic retinopathy and surgical inexperience resulted in an increased rate of retinopathy progression.
From the Department of Ophthalmology, Eye Institute, Medical College of Wisconsin, Milwaukee (Drs Mittra, Borrillo, Dev, Mieler, and Koenig); and Retina Associates of Cleveland, Cleveland, Ohio (Dr Mittra). Dr Mieler is now with the Cullen Eye Institute, Baylor College of Medicine, Houston, Tex.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2000;118(7):1011-1012.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Effect of Perioperative Glycemic Control in Progression of Diabetic Retinopathy and Maculopathy
Suto et al.
Arch Ophthalmol 2006;124:38-45.
ABSTRACT
| FULL TEXT
A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes
Squirrell et al.
Br J Ophthalmol 2002;86:565-571.
ABSTRACT
| FULL TEXT
Regular review: Effect of increasing age on cataract surgery outcomes in very elderly patients
Wong
BMJ 2001;322:1104-1106.
FULL TEXT
Efficacy of Octreotide in the Therapy of Severe Nonproliferative and Early Proliferative Diabetic Retinopathy: A Randomized Controlled Study: Response to Gehrs
Grant et al.
Diabetes Care 2001;24:182-a-183.
FULL TEXT
|